CompoAtlas

Raspberry Ketone

Retirée du marché américain le 28 April 2022 (selon le DSLD)

Biomedx Research, food supplement from the US market

Label withdrawn from the US market. Raspberry Ketone (Biomedx Research), a food supplement au code-barres 689076034388, is described by its US market label. If sold in France, it would be subject to 2 points of French or European regulation, detailed below. The formula sold in Europe under the same name may differ.

Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.

Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.

Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.

If this product were sold in France

A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.

Label composition

Brand
Biomedx Research
Barcode
689076034388
Form
Capsule
One serving
2 capsules
Servings
up to 1 serving per day
Other ingredients (in English, as written)
Vegetable Cellulose Capsule, Calcium Carbonate, Magnesium Stearate
Ingredient (as written, in English)CategoryPer serving
Proprietary FormulaBlend1,200 mg
Raspberry KetoneOther substancenot stated
African Mango extract (Irvingia gabonensis)Plantnot stated
Acai (Euterpe oleracea)Plantnot stated
Green Tea extract (Camellia sinensis)Plantnot stated
ResveratrolOther substancenot stated
Caffeine AnhydrousOther substancenot stated
Apple Cider VinegarPlantnot stated
KelpOthernot stated
Grapefruit (Citrus paradisi)Plantnot stated

This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • African Mango extract
    Read the warning, when it applies and the studies cited

    AFRICAN WILD MANGO - IRVINGIA GABONENSIS

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Ross 2011; Ngondi et al. 2009; Adamson et al. 1986).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: Antioxidant, cholesterol, glucose.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant.

    Contraindications

    Condition of application: Weight management.

    Do not use if you are pregnant.

    Known adverse reactions

    Stop use if you experience symptoms of hypoglycaemia including feelings of anxiety, dizziness, tremor, sweating, nausea or headache (Adamson et al. 1986; Ngondi et al. 2009; Oben et al. 2008a,b).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 29 August 2025

  • Acai
    Read the warning, when it applies and the studies cited

    ACAI – EUTERPE OLERACEA

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (derMarderosian and Beutler 2008).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (derMarderosian and Beutler 2008).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 24 April 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).

Photograph the packaging

Brand : Biomedx Research

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

List recorded in 2016. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line